BMP9 was reported to be a tumor suppressor in breast cancer [15,16] and lung cancer [17], but it can promote the progress of ovarian cancer [18] and liver cancer cells [19] and its function in bladder cancer has not been reported. This evidence concerns the gene GDF2 and urinary bladder carcinoma.